Skip to content

The study to investigate the anti-metabolic effect of high-carotenoids and glucosinolates included kale "Koiaona"

The study to investigate the anti-metabolic effect of high-carotenoids and glucosinolates included kale "Koiaona" - Functional evaluation of kela

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018206
Enrollment
40
Registered
2015-07-15
Start date
2015-07-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Over weight(BMI&gt

Interventions

The subjects take the test food during 3 months. The subjects take the placebo food during 3 months.

Sponsors

Kyoto Prefectural University Of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1)30yrs<=age<=65yrs 2)Male 3)Outpatients 4)BMI>=25 5)Those who are able to take the test foods during 3 months. 6)Those who don't change the diet or exercise regimen during the study period 7)consent document

Exclusion criteria

Exclusion criteria: 1)People corresponding to the following *LDL-Cholesterol>=180mg/dl *Systolic blood pressure>=160mmHg *Diastolic blood pressure>=90mmHg *Hemoglobin A1c>=6.5% *Fasting blood glucose>=140mg/dl 2)Smokers 3)People of dyslipidemia treatment during administration 4)serious heart disease(heart failure,myocardial infarction,myocarditis,etc.)liver disease(liver failure symptoms (fulminant hepatitis),patients with cirrhosis of the liver,liver tumor),renal disease(nephrotic syndrome,renal failure (acute and chronic), uremia, merged, etc.hydronephrosis) 5)Patients who took antihypertensive drugs 6)Those who have participated in other clinical trials within before consent get one month,and those who are currently participating in other clinical trials. 7)At the physician's judgment,who it is determined that there is a possibility that either increased risk to the subject,or sufficient data not obtained

Design outcomes

Primary

MeasureTime frame
Visceral fat area

Countries

Japan

Contacts

Public ContactYoshitada Hira

IMEQRD Co., Ltd. Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026